In January, the registered clinical trial of "Gastric Bypass Stent System" was initiated.
In March, the Gastric Bypass Stent was successfully implanted in the first subject of the registered clinical trial.
In May, Tongee received investments from "Baidu Ventures" and "Everest Venture Capital".
In June,Tongee's brand new R&D center that integrates versatile functions including scientific research, trial manufacturing, manufacturing, inspection and other functions was officially established in Binjiang District, Hangzhou.
In November,Tongee Shanghai Branch "Shuchuang Tech" was officially established, kicking off its comprehensive layout in the East China market.
In December,Tongee donated thousands of Covid-19 prevention items, contributing to Covid-19 prevention and control in Zhejiang Province.